nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazamide—ABCC8—penis—urinary bladder cancer	0.142	0.437	CbGeAlD
Tolazamide—KCNJ1—renal system—urinary bladder cancer	0.0414	0.127	CbGeAlD
Tolazamide—ABCC8—prostate gland—urinary bladder cancer	0.0339	0.104	CbGeAlD
Tolazamide—ABCC8—seminal vesicle—urinary bladder cancer	0.0287	0.0883	CbGeAlD
Tolazamide—ABCC8—smooth muscle tissue—urinary bladder cancer	0.024	0.0739	CbGeAlD
Tolazamide—ABCC8—renal system—urinary bladder cancer	0.0231	0.0711	CbGeAlD
Tolazamide—KCNJ11—female reproductive system—urinary bladder cancer	0.0201	0.0619	CbGeAlD
Tolazamide—Eruption—Gemcitabine—urinary bladder cancer	0.015	0.0226	CcSEcCtD
Tolazamide—Inappropriate antidiuretic hormone secretion—Cisplatin—urinary bladder cancer	0.0148	0.0223	CcSEcCtD
Tolazamide—Reaction gastrointestinal—Methotrexate—urinary bladder cancer	0.0141	0.0213	CcSEcCtD
Tolazamide—Heartburn—Fluorouracil—urinary bladder cancer	0.0131	0.0198	CcSEcCtD
Tolazamide—Pancytopenia—Mitomycin—urinary bladder cancer	0.013	0.0195	CcSEcCtD
Tolazamide—Ill-defined disorder—Valrubicin—urinary bladder cancer	0.0128	0.0193	CcSEcCtD
Tolazamide—Malaise—Valrubicin—urinary bladder cancer	0.0124	0.0188	CcSEcCtD
Tolazamide—KCNJ11—lymph node—urinary bladder cancer	0.0118	0.0362	CbGeAlD
Tolazamide—Glipizide—PPARG—urinary bladder cancer	0.0117	1	CrCbGaD
Tolazamide—Discomfort—Valrubicin—urinary bladder cancer	0.0116	0.0175	CcSEcCtD
Tolazamide—Erythema—Mitomycin—urinary bladder cancer	0.00951	0.0143	CcSEcCtD
Tolazamide—Feeling abnormal—Valrubicin—urinary bladder cancer	0.00929	0.014	CcSEcCtD
Tolazamide—Ill-defined disorder—Mitomycin—urinary bladder cancer	0.00882	0.0133	CcSEcCtD
Tolazamide—Malaise—Mitomycin—urinary bladder cancer	0.00858	0.0129	CcSEcCtD
Tolazamide—Leukopenia—Mitomycin—urinary bladder cancer	0.00851	0.0128	CcSEcCtD
Tolazamide—Asthenia—Valrubicin—urinary bladder cancer	0.00808	0.0122	CcSEcCtD
Tolazamide—Discomfort—Mitomycin—urinary bladder cancer	0.008	0.0121	CcSEcCtD
Tolazamide—Pruritus—Valrubicin—urinary bladder cancer	0.00797	0.012	CcSEcCtD
Tolazamide—Eruption—Methotrexate—urinary bladder cancer	0.00765	0.0115	CcSEcCtD
Tolazamide—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.0076	0.0115	CcSEcCtD
Tolazamide—Dizziness—Valrubicin—urinary bladder cancer	0.00745	0.0112	CcSEcCtD
Tolazamide—Eruption—Epirubicin—urinary bladder cancer	0.00716	0.0108	CcSEcCtD
Tolazamide—Rash—Valrubicin—urinary bladder cancer	0.0071	0.0107	CcSEcCtD
Tolazamide—Headache—Valrubicin—urinary bladder cancer	0.00706	0.0106	CcSEcCtD
Tolazamide—Haemolytic anaemia—Cisplatin—urinary bladder cancer	0.0069	0.0104	CcSEcCtD
Tolazamide—Nausea—Valrubicin—urinary bladder cancer	0.00669	0.0101	CcSEcCtD
Tolazamide—Fatigue—Mitomycin—urinary bladder cancer	0.00669	0.0101	CcSEcCtD
Tolazamide—Eruption—Doxorubicin—urinary bladder cancer	0.00663	0.00999	CcSEcCtD
Tolazamide—Pancytopenia—Thiotepa—urinary bladder cancer	0.00652	0.00983	CcSEcCtD
Tolazamide—Feeling abnormal—Mitomycin—urinary bladder cancer	0.0064	0.00965	CcSEcCtD
Tolazamide—Hyponatraemia—Cisplatin—urinary bladder cancer	0.00625	0.00943	CcSEcCtD
Tolazamide—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00571	0.00861	CcSEcCtD
Tolazamide—Asthenia—Mitomycin—urinary bladder cancer	0.00557	0.0084	CcSEcCtD
Tolazamide—Pancytopenia—Gemcitabine—urinary bladder cancer	0.00548	0.00827	CcSEcCtD
Tolazamide—Pancytopenia—Fluorouracil—urinary bladder cancer	0.00539	0.00813	CcSEcCtD
Tolazamide—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.00518	0.00782	CcSEcCtD
Tolazamide—Dizziness—Mitomycin—urinary bladder cancer	0.00513	0.00774	CcSEcCtD
Tolazamide—Pancytopenia—Cisplatin—urinary bladder cancer	0.00511	0.00771	CcSEcCtD
Tolazamide—Jaundice cholestatic—Epirubicin—urinary bladder cancer	0.00501	0.00756	CcSEcCtD
Tolazamide—Rash—Mitomycin—urinary bladder cancer	0.00489	0.00738	CcSEcCtD
Tolazamide—Headache—Mitomycin—urinary bladder cancer	0.00486	0.00733	CcSEcCtD
Tolazamide—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.0048	0.00725	CcSEcCtD
Tolazamide—Erythema—Thiotepa—urinary bladder cancer	0.00478	0.00721	CcSEcCtD
Tolazamide—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00472	0.00712	CcSEcCtD
Tolazamide—Pancytopenia—Etoposide—urinary bladder cancer	0.00468	0.00706	CcSEcCtD
Tolazamide—Jaundice cholestatic—Doxorubicin—urinary bladder cancer	0.00464	0.007	CcSEcCtD
Tolazamide—Nausea—Mitomycin—urinary bladder cancer	0.00461	0.00695	CcSEcCtD
Tolazamide—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.00442	0.00667	CcSEcCtD
Tolazamide—Leukopenia—Thiotepa—urinary bladder cancer	0.00428	0.00646	CcSEcCtD
Tolazamide—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.00414	0.00624	CcSEcCtD
Tolazamide—Agranulocytosis—Etoposide—urinary bladder cancer	0.0041	0.00619	CcSEcCtD
Tolazamide—Erythema—Gemcitabine—urinary bladder cancer	0.00402	0.00607	CcSEcCtD
Tolazamide—Erythema—Fluorouracil—urinary bladder cancer	0.00396	0.00597	CcSEcCtD
Tolazamide—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.00383	0.00577	CcSEcCtD
Tolazamide—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00382	0.00576	CcSEcCtD
Tolazamide—Erythema—Cisplatin—urinary bladder cancer	0.00375	0.00566	CcSEcCtD
Tolazamide—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.00373	0.00563	CcSEcCtD
Tolazamide—Malaise—Gemcitabine—urinary bladder cancer	0.00363	0.00547	CcSEcCtD
Tolazamide—Leukopenia—Gemcitabine—urinary bladder cancer	0.0036	0.00543	CcSEcCtD
Tolazamide—Leukopenia—Fluorouracil—urinary bladder cancer	0.00354	0.00534	CcSEcCtD
Tolazamide—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.00348	0.00525	CcSEcCtD
Tolazamide—Dyspepsia—Thiotepa—urinary bladder cancer	0.00344	0.00518	CcSEcCtD
Tolazamide—Discomfort—Gemcitabine—urinary bladder cancer	0.00338	0.0051	CcSEcCtD
Tolazamide—Malaise—Cisplatin—urinary bladder cancer	0.00338	0.0051	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00337	0.00508	CcSEcCtD
Tolazamide—Fatigue—Thiotepa—urinary bladder cancer	0.00337	0.00508	CcSEcCtD
Tolazamide—Leukopenia—Cisplatin—urinary bladder cancer	0.00336	0.00506	CcSEcCtD
Tolazamide—Discomfort—Fluorouracil—urinary bladder cancer	0.00333	0.00502	CcSEcCtD
Tolazamide—Hypoglycaemia—Epirubicin—urinary bladder cancer	0.00328	0.00494	CcSEcCtD
Tolazamide—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00322	0.00485	CcSEcCtD
Tolazamide—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00322	0.00485	CcSEcCtD
Tolazamide—Hyponatraemia—Epirubicin—urinary bladder cancer	0.00321	0.00484	CcSEcCtD
Tolazamide—Ill-defined disorder—Etoposide—urinary bladder cancer	0.00319	0.00481	CcSEcCtD
Tolazamide—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00316	0.00477	CcSEcCtD
Tolazamide—Discomfort—Cisplatin—urinary bladder cancer	0.00315	0.00476	CcSEcCtD
Tolazamide—Urticaria—Thiotepa—urinary bladder cancer	0.0031	0.00468	CcSEcCtD
Tolazamide—Malaise—Etoposide—urinary bladder cancer	0.0031	0.00467	CcSEcCtD
Tolazamide—Vertigo—Etoposide—urinary bladder cancer	0.00309	0.00466	CcSEcCtD
Tolazamide—Leukopenia—Etoposide—urinary bladder cancer	0.00308	0.00464	CcSEcCtD
Tolazamide—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.00303	0.00457	CcSEcCtD
Tolazamide—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.003	0.00452	CcSEcCtD
Tolazamide—Hyponatraemia—Doxorubicin—urinary bladder cancer	0.00297	0.00448	CcSEcCtD
Tolazamide—Discomfort—Etoposide—urinary bladder cancer	0.00289	0.00436	CcSEcCtD
Tolazamide—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00284	0.00429	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00284	0.00428	CcSEcCtD
Tolazamide—Fatigue—Gemcitabine—urinary bladder cancer	0.00283	0.00427	CcSEcCtD
Tolazamide—Pancytopenia—Methotrexate—urinary bladder cancer	0.0028	0.00423	CcSEcCtD
Tolazamide—Asthenia—Thiotepa—urinary bladder cancer	0.0028	0.00422	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00279	0.0042	CcSEcCtD
Tolazamide—Abdominal distension—Epirubicin—urinary bladder cancer	0.00278	0.0042	CcSEcCtD
Tolazamide—Pruritus—Thiotepa—urinary bladder cancer	0.00276	0.00416	CcSEcCtD
Tolazamide—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00275	0.00414	CcSEcCtD
Tolazamide—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00271	0.00408	CcSEcCtD
Tolazamide—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.0027	0.00407	CcSEcCtD
Tolazamide—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00266	0.00401	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00264	0.00398	CcSEcCtD
Tolazamide—Pancytopenia—Epirubicin—urinary bladder cancer	0.00262	0.00396	CcSEcCtD
Tolazamide—Dizziness—Thiotepa—urinary bladder cancer	0.00258	0.00389	CcSEcCtD
Tolazamide—Abdominal distension—Doxorubicin—urinary bladder cancer	0.00257	0.00388	CcSEcCtD
Tolazamide—Urticaria—Fluorouracil—urinary bladder cancer	0.00256	0.00387	CcSEcCtD
Tolazamide—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.00252	0.0038	CcSEcCtD
Tolazamide—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00252	0.0038	CcSEcCtD
Tolazamide—Rash—Thiotepa—urinary bladder cancer	0.00246	0.00371	CcSEcCtD
Tolazamide—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00246	0.00371	CcSEcCtD
Tolazamide—Headache—Thiotepa—urinary bladder cancer	0.00245	0.00369	CcSEcCtD
Tolazamide—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00243	0.00366	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00242	0.00365	CcSEcCtD
Tolazamide—Fatigue—Etoposide—urinary bladder cancer	0.00242	0.00365	CcSEcCtD
Tolazamide—Asthenia—Gemcitabine—urinary bladder cancer	0.00236	0.00355	CcSEcCtD
Tolazamide—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.00233	0.00352	CcSEcCtD
Tolazamide—Pruritus—Gemcitabine—urinary bladder cancer	0.00232	0.0035	CcSEcCtD
Tolazamide—Nausea—Thiotepa—urinary bladder cancer	0.00232	0.0035	CcSEcCtD
Tolazamide—Feeling abnormal—Etoposide—urinary bladder cancer	0.00231	0.00348	CcSEcCtD
Tolazamide—Agranulocytosis—Epirubicin—urinary bladder cancer	0.0023	0.00347	CcSEcCtD
Tolazamide—Pruritus—Fluorouracil—urinary bladder cancer	0.00228	0.00344	CcSEcCtD
Tolazamide—Urticaria—Etoposide—urinary bladder cancer	0.00223	0.00336	CcSEcCtD
Tolazamide—Asthenia—Cisplatin—urinary bladder cancer	0.0022	0.00331	CcSEcCtD
Tolazamide—Dizziness—Fluorouracil—urinary bladder cancer	0.00214	0.00322	CcSEcCtD
Tolazamide—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00213	0.00321	CcSEcCtD
Tolazamide—Rash—Gemcitabine—urinary bladder cancer	0.00207	0.00312	CcSEcCtD
Tolazamide—Erythema—Methotrexate—urinary bladder cancer	0.00206	0.0031	CcSEcCtD
Tolazamide—Headache—Gemcitabine—urinary bladder cancer	0.00206	0.0031	CcSEcCtD
Tolazamide—Rash—Fluorouracil—urinary bladder cancer	0.00204	0.00307	CcSEcCtD
Tolazamide—Headache—Fluorouracil—urinary bladder cancer	0.00202	0.00305	CcSEcCtD
Tolazamide—Asthenia—Etoposide—urinary bladder cancer	0.00201	0.00303	CcSEcCtD
Tolazamide—Pruritus—Etoposide—urinary bladder cancer	0.00198	0.00299	CcSEcCtD
Tolazamide—Nausea—Gemcitabine—urinary bladder cancer	0.00195	0.00294	CcSEcCtD
Tolazamide—Rash—Cisplatin—urinary bladder cancer	0.00193	0.00291	CcSEcCtD
Tolazamide—Erythema—Epirubicin—urinary bladder cancer	0.00193	0.0029	CcSEcCtD
Tolazamide—Nausea—Fluorouracil—urinary bladder cancer	0.00192	0.00289	CcSEcCtD
Tolazamide—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.00191	0.00288	CcSEcCtD
Tolazamide—Malaise—Methotrexate—urinary bladder cancer	0.00186	0.0028	CcSEcCtD
Tolazamide—Dizziness—Etoposide—urinary bladder cancer	0.00185	0.0028	CcSEcCtD
Tolazamide—Vertigo—Methotrexate—urinary bladder cancer	0.00185	0.00279	CcSEcCtD
Tolazamide—Leukopenia—Methotrexate—urinary bladder cancer	0.00184	0.00278	CcSEcCtD
Tolazamide—Nausea—Cisplatin—urinary bladder cancer	0.00182	0.00274	CcSEcCtD
Tolazamide—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.00179	0.00269	CcSEcCtD
Tolazamide—Erythema—Doxorubicin—urinary bladder cancer	0.00178	0.00269	CcSEcCtD
Tolazamide—Rash—Etoposide—urinary bladder cancer	0.00177	0.00267	CcSEcCtD
Tolazamide—Headache—Etoposide—urinary bladder cancer	0.00176	0.00265	CcSEcCtD
Tolazamide—Malaise—Epirubicin—urinary bladder cancer	0.00174	0.00262	CcSEcCtD
Tolazamide—Discomfort—Methotrexate—urinary bladder cancer	0.00173	0.00261	CcSEcCtD
Tolazamide—Vertigo—Epirubicin—urinary bladder cancer	0.00173	0.00261	CcSEcCtD
Tolazamide—Leukopenia—Epirubicin—urinary bladder cancer	0.00172	0.0026	CcSEcCtD
Tolazamide—Nausea—Etoposide—urinary bladder cancer	0.00167	0.00251	CcSEcCtD
Tolazamide—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00165	0.00249	CcSEcCtD
Tolazamide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00164	0.00248	CcSEcCtD
Tolazamide—Discomfort—Epirubicin—urinary bladder cancer	0.00162	0.00244	CcSEcCtD
Tolazamide—Malaise—Doxorubicin—urinary bladder cancer	0.00161	0.00242	CcSEcCtD
Tolazamide—Vertigo—Doxorubicin—urinary bladder cancer	0.0016	0.00241	CcSEcCtD
Tolazamide—Leukopenia—Doxorubicin—urinary bladder cancer	0.0016	0.00241	CcSEcCtD
Tolazamide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00154	0.00232	CcSEcCtD
Tolazamide—Discomfort—Doxorubicin—urinary bladder cancer	0.0015	0.00226	CcSEcCtD
Tolazamide—Dyspepsia—Methotrexate—urinary bladder cancer	0.00148	0.00223	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00145	0.00219	CcSEcCtD
Tolazamide—Fatigue—Methotrexate—urinary bladder cancer	0.00145	0.00218	CcSEcCtD
Tolazamide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.00142	0.00215	CcSEcCtD
Tolazamide—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00138	0.00209	CcSEcCtD
Tolazamide—Dyspepsia—Epirubicin—urinary bladder cancer	0.00138	0.00209	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00136	0.00205	CcSEcCtD
Tolazamide—Fatigue—Epirubicin—urinary bladder cancer	0.00136	0.00204	CcSEcCtD
Tolazamide—Urticaria—Methotrexate—urinary bladder cancer	0.00133	0.00201	CcSEcCtD
Tolazamide—Feeling abnormal—Epirubicin—urinary bladder cancer	0.0013	0.00195	CcSEcCtD
Tolazamide—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00128	0.00193	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00126	0.00189	CcSEcCtD
Tolazamide—Fatigue—Doxorubicin—urinary bladder cancer	0.00125	0.00189	CcSEcCtD
Tolazamide—Urticaria—Epirubicin—urinary bladder cancer	0.00125	0.00188	CcSEcCtD
Tolazamide—Asthenia—Methotrexate—urinary bladder cancer	0.00121	0.00182	CcSEcCtD
Tolazamide—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.0012	0.00181	CcSEcCtD
Tolazamide—Pruritus—Methotrexate—urinary bladder cancer	0.00119	0.00179	CcSEcCtD
Tolazamide—Urticaria—Doxorubicin—urinary bladder cancer	0.00116	0.00174	CcSEcCtD
Tolazamide—Asthenia—Epirubicin—urinary bladder cancer	0.00113	0.0017	CcSEcCtD
Tolazamide—Pruritus—Epirubicin—urinary bladder cancer	0.00111	0.00168	CcSEcCtD
Tolazamide—Dizziness—Methotrexate—urinary bladder cancer	0.00111	0.00167	CcSEcCtD
Tolazamide—Rash—Methotrexate—urinary bladder cancer	0.00106	0.0016	CcSEcCtD
Tolazamide—Headache—Methotrexate—urinary bladder cancer	0.00105	0.00159	CcSEcCtD
Tolazamide—Asthenia—Doxorubicin—urinary bladder cancer	0.00104	0.00157	CcSEcCtD
Tolazamide—Dizziness—Epirubicin—urinary bladder cancer	0.00104	0.00157	CcSEcCtD
Tolazamide—Pruritus—Doxorubicin—urinary bladder cancer	0.00103	0.00155	CcSEcCtD
Tolazamide—Nausea—Methotrexate—urinary bladder cancer	0.000998	0.0015	CcSEcCtD
Tolazamide—Rash—Epirubicin—urinary bladder cancer	0.000991	0.00149	CcSEcCtD
Tolazamide—Headache—Epirubicin—urinary bladder cancer	0.000985	0.00148	CcSEcCtD
Tolazamide—Dizziness—Doxorubicin—urinary bladder cancer	0.000962	0.00145	CcSEcCtD
Tolazamide—Nausea—Epirubicin—urinary bladder cancer	0.000934	0.00141	CcSEcCtD
Tolazamide—Rash—Doxorubicin—urinary bladder cancer	0.000917	0.00138	CcSEcCtD
Tolazamide—Headache—Doxorubicin—urinary bladder cancer	0.000911	0.00137	CcSEcCtD
Tolazamide—Nausea—Doxorubicin—urinary bladder cancer	0.000864	0.0013	CcSEcCtD
